Patient Square Capital, a healthcare investment firm, completed the acquisition of the remaining stake in Eargo, a medical device company for $53m. The transaction is expected to close in the first quarter of 2024 and is subject to customary closing conditions. Upon completion of the transaction, Eargo will become a private company and will no longer be publicly listed or traded on Nasdaq.